凯镛KAIYONG品牌怎么样 申请店铺

我要投票 凯镛KAIYONG在胶原蛋白粉行业中的票数:445 更新时间:2025-09-01
凯镛KAIYONG是哪个国家的品牌?「凯镛KAIYONG」是 天津凯镛药业有限公司 旗下著名品牌。该品牌发源于天津市,由创始人曹利东在1989-09-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力凯镛KAIYONG品牌出海!将品牌入驻外推网,定制凯镛KAIYONG品牌推广信息,可以显著提高凯镛KAIYONG产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

凯镛KAIYONG怎么样

天津凯镛药业有限公司是一家坐落于天津经济技术开发区的现代化制药企业,成立于1989年,公司注册资本为人民币4000万元。

公司是专业从事药品、保健品、食品的研发、生产、销售的高科技现代化企业,企业创始人为国际中医男科学会主席、中国中医药学会男科学会会长曹开镛教授。

公司拥有口服液车间与固体制剂车间,标准净化密闭制药厂房及生化工程设备,均具备国内专业水平。公司于2003年9月份顺利通过了国家药品生产规范考核标准的GMP认证。公司现有员工近200人,其中专业技术人员26%,均具备大学水平,各职能部门分工明确。

现公司产品品种共四十余种,规格众多,其中包括以凯镛乌鸡桂圆养血口服液、凯镛小儿咳喘灵口服液为代表的OTC药品6种,更有以曹开镛男士营养液、凯镛芦荟胶囊、凯镛蛋白粉、凯镛大豆异黄酮为代表的保健食品40余种,类型包括口服液、胶囊剂、粉剂、片剂、茶剂,基本涵盖了保健品的全部种类。

天津凯镛药业有限公司与各地各级代理商及终端连锁药房合作,公司内部销售人员予以支持辅佐,共同进行销售推广,无零售业务,产品销售终端已达3000余家。整体销售团队现有近百人,分级分区管理,权责分明,覆盖面广,渠道畅通。目前公司销售市场已覆盖全国各大省市,并且获得了用户的广泛好评和信赖。

2014年7月25日,天津凯镛药业有限公司生产研发基地建设(一期)项目正式开工,整个项目总建筑面积33956.12平方米。

目前,项目主体结构已封顶,二次结构已验收合格,预计完工时间为2016年末。新厂投产后,公司的生产规模、产能将得到整体提升。


Tianjin kaiyong Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise located in Tianjin Economic and Technological Development Zone. It was founded in 1989 with a registered capital of 40 million yuan. The company is a high-tech modern enterprise specializing in the research, development, production and sales of drugs, health products and food. The founder of the company is Professor Cao kaiyong, chairman of international society of andrology of traditional Chinese medicine and President of Andrology society of Chinese medicine. The company has oral liquid workshop, solid preparation workshop, standard purification closed Pharmaceutical Workshop and biochemical engineering equipment, all with domestic professional level. In September 2003, the company successfully passed the GMP certification of the national drug production standards. The company has nearly 200 employees, including 26% of professional and technical personnel, all of whom have university level and clear division of labor in each functional department. At present, the company has more than 40 kinds of products with various specifications, including 6 OTC drugs represented by kaiyong Wuji Guiyuan blood nourishing oral liquid, kaiyong Xiaoer Kechuanling oral liquid, and more than 40 health food represented by Cao kaiyong men's nutrition liquid, kaiyong aloe capsule, kaiyong protein powder and kaiyong soybean isoflavone, including oral liquid, capsule, powder, tablet Tea agent basically covers all kinds of health products. Tianjin kaiyong Pharmaceutical Co., Ltd. cooperates with agents at all levels and terminal chain pharmacies, with the support and assistance of the company's internal sales personnel to jointly carry out sales promotion. There is no retail business, and there are more than 3000 product sales terminals. The overall sales team now has nearly 100 people, who are managed in different levels and areas, with clear rights and responsibilities, wide coverage and smooth channels. At present, the company's sales market has covered all major provinces and cities in the country, and has been widely praised and trusted by users. On July 25, 2014, the construction of production and R & D base (phase I) of Tianjin kaiyong Pharmaceutical Co., Ltd. was officially started, with a total construction area of 33956.12 square meters. At present, the main structure of the project has been capped, the secondary structure has been accepted, and the expected completion time is the end of 2016. After the new plant is put into operation, the production scale and capacity of the company will be improved as a whole.

本文链接: https://brand.waitui.com/583df2b43.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

东吴证券:新一代智驾架构集中落地,继续看好智能化主线

36氪获悉,东吴证券发布研报称,2025年汽车智能化或是拐点之年。城市NOA(L3智能化核心体验)普及是推动智能化成为消费者购车前三考虑因素的力量。目前根据“引领车企新车周期—终端草根调研—爆款车型验证”体系将紧密跟踪“L3智能化渗透率”2025-2027年从10%-50%-80%+的变化过程。整车未来或分为三类公司: B端Robotaxi运营+ C端个性化品牌+整车高端制造。建议关注VLA/下一代智驾架构上车及渗透率和买单意愿等。

45分钟前

协鑫科技:颗粒硅维持4万余元每吨售价下,公司8月底至9月可以恢复盈利

8月31日上午,协鑫科技首席财务官杨文忠在公司业绩说明会上介绍,随着行业整治内卷力度的加大和产业有序竞争的推进,在保持目前颗粒硅4万余元每吨售价的情况下,公司8月底至9月左右可以恢复盈利,即公司报表层面的盈利。(新浪财经)

45分钟前

东吴证券:算力行情仍未结束,左侧积极布局AI+创新药等方向

36氪获悉,东吴证券发布研报称,6-8月市场主线围绕人工智能展开,目前行情主要集中于上游基础设施类硬件,其中景气确定性最高的海外链光模块、PCB等在6月率先启动,8月中旬以寒武纪为核心的国产算力正式开始补涨。在大盘量能充沛且产业逻辑没有出现明显瑕疵的情况下,并不认为算力行情即将结束,但对于场外持币者,上游硬件的强赚钱效应令人躁动不安,而客观上获利盘的不断增厚会带来一定止盈压力,主观层面持续累积的涨幅又难免使风险偏好较低的资金焦虑。

45分钟前

山高控股:2025年上半年净利4.76亿,同比增长506%

36氪获悉,山高控股发布半年报,实现营业收入25.03亿元,其中来自新兴产业的收入占比96%,净利润4.76亿元,同比增长506%。资产结构方面,山高控股总资产规模达675.31亿元,其中新兴产业资产规模约519.76亿元,占总资产规模的76.97%。

45分钟前

Infini Capital与优必选达成资本战略合作

36氪获悉,日前,优必选与投资机构Infini Capital正式签署10亿美金战略伙伴合作协议。双方合作将围绕资金支持和产业协同两方面展开。根据合作协议,Infini Capital旗下高新技术基金为优必选提供一笔总额为10亿美金的战略融资授信额度,融资方式包括参与配售、认购可转债、授予现金提款权等。

45分钟前

本页详细列出关于凯镛KAIYONG的品牌信息,含品牌所属公司介绍,凯镛KAIYONG所处行业的品牌地位及优势。
咨询